Author:
Feriinz Klaus,Sandhoff Konrad
Publisher
Springer Berlin Heidelberg
Reference79 articles.
1. Albouz, S., Hauw, J.J., Berwald-Netter, Y., Boutry, J.M., Bourdon, R. and Baumann, N. (1981) Biomed. Express. 35, 218–220.
2. Barton, N.W., Brady, R.O., Dambrosia, J.M., Di Bisceglie, A.M., Doppelt, S.H., Hill, S.C., Mankin, H.J., Murray, G.J., Parker, R.I., Argoff, C.E., Grewal, R.P., Yu, K.-T., and Collaborators (1991). Replacement therapy for inherited enzyme deficiency-macrophage targeted glucocerebrosidase for Gaucher’s disease. N. Engl. J. Med. 324: 1464–1470.
3. Bayever, E., Kamani, N., Ferreira, P., Machin, G.A., Yudkoff, M., Conrad, K., Palmieri, M., Radcliffe, J., Wenger, D.A., and August, C.S. (1992) Bone marrow transplantation for Niemann-Pick type 1A disease. J. Inher. Met. Dis. 15, 919–928.
4. Bembi, B., Comelli, M., Scaggiante, B., Pineschi, A., Rapelli, S., Gornati, R., Montorfano, G., Berra, B, Agosti, E, and Romeo, D. (1992) Treatment of sphingomyelinase deficiency by repeated implantations of amniotic epethelial cells. Am. J. Med. Genet. 44, 527–533.
5. Bernert, J. T., and Ullman, M. D. (1981). Biosynthesis of sphingomyelin from erythro- ceramide and phosphatidylcholine by a microsomal cholinephosphotransferase. Biochim. Biophys. Acta 666: 99–109.